ADAG
$3.91
Adagene Inc., a clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People's Republic of China.
Intraday
Recent News
Adagene Spotlights ADG126 at Leerink, Teases New MSS Colorectal Cancer Data Update Soon
Adagene (NASDAQ:ADAG) outlined its clinical and strategic priorities at Leerink Partners’ global healthcare conference, with Chief Strategy Officer Mickael Chane-Du focusing primarily on the company’s lead program, ADG126, and its progress in metastatic microsatellite-stable colorectal cancer (MSS C
Adagene Spotlights ADG126+KEYTRUDA Data, Late-Line MSS-CRC Focus in Oppenheimer Conference Talk
Adagene (NASDAQ:ADAG) highlighted updated details around its lead immuno-oncology program, ADG126, during an Oppenheimer discussion featuring Chief Strategy Officer Mickael Chane-Du. The company is developing ADG126 as a “masked” anti-CTLA-4 antibody intended to improve the safety of CTLA-4 blockade
Moderna's Shares Climb 5.3% as Investors Revisit Biotech Leaders
MRNA shares jumped 5.3% as investors rotated into large-cap biotech, betting on its expanding pipeline in volatile trade.
Penny Stocks To Watch In January 2026
As the U.S. markets grapple with recent declines and rising Treasury yields, investors are keenly observing potential opportunities in various sectors. Penny stocks, while often seen as relics of past market trends, continue to offer intriguing possibilities for those willing to explore smaller or newer companies at accessible price points. By focusing on solid financials and growth potential, these stocks can present unique opportunities for investors looking to tap into under-the-radar...
3 Promising Penny Stocks With Market Caps Over $30M
Major stock indexes in the United States have recently experienced a surge, driven by gains in technology shares and positive economic indicators. While the term "penny stocks" might seem outdated, it still refers to shares of smaller or newer companies that can offer significant potential for growth. By focusing on those with solid financial foundations, investors can uncover opportunities that may provide stability and upside potential.